GDPD5 and neurodegenerative disease: Importantly, Gde2-knockout in mice leads to progressive neurodegeneration with pathologies reflecting human neurodegenerative disease, which was accompanied by reduced glypican release, implicating dysregulated GPI-anchored protein activity in neurodegeneration (Cave et al., 2017).